Mediq acquires 5.87% of its own shares from SSAO
As from today, Mediq, the international supplier of medical devices and pharmaceuticals, owns the 3,535,215 Mediq shares formerly held by Stichting Samenwerking Apothekers OPG (SSAO). As a result, these shares carry no voting rights or dividend rights.
This means that the number of issued shares entitled to vote has been reduced by 5.87% from 60,173,120 to 56,637,905. Mediq intends to cancel these shares, for which the approval from the shareholders meeting is required.
The SSAO was founded when the former cooperative OPG was listed on the stock exchange in 1992. The foundation’s purpose was to support projects in the field of pharmaceutical care to enhance its quality and effectiveness. Following consultation between the SSAO, Mediq and the tax authorities regarding the distributions by the SSAO, it was recently decided to transfer the remaining assets and liabilities to Mediq and to liquidate the SSAO. This has already been reported in the Q2 results press release dated 28 July 2011.
Mediq has consolidated the SSAO as of 28 July. The consolidation has a limited one-off negative effect on Mediq's equity (- € 9.8 million) and cash flow (- € 5.6 million), which will be reported in Q3 2011. It will not have any effect on Mediq's future results; the earnings per share will increase, however.
The SSAO was founded when the former cooperative OPG was listed on the stock exchange in 1992. The foundation’s purpose was to support projects in the field of pharmaceutical care to enhance its quality and effectiveness. Following consultation between the SSAO, Mediq and the tax authorities regarding the distributions by the SSAO, it was recently decided to transfer the remaining assets and liabilities to Mediq and to liquidate the SSAO. This has already been reported in the Q2 results press release dated 28 July 2011.
Mediq has consolidated the SSAO as of 28 July. The consolidation has a limited one-off negative effect on Mediq's equity (- € 9.8 million) and cash flow (- € 5.6 million), which will be reported in Q3 2011. It will not have any effect on Mediq's future results; the earnings per share will increase, however.